The fund purchased 27,685 shares of the biotechnology company’s stock, valued at approximately $3,269,000. Smith Graham & Co. Investment …
The fund purchased 27,685 shares of the biotechnology company’s stock, valued at approximately $3,269,000. Smith Graham & Co. Investment …
0 Comments